Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (635)	11/17/2001 2:43:37 PM
From: Luke	Read Replies (1) of 1833

Rick, Thanks. OK, I remember now about axiom-arena deal. I need to re-read as I am not familiar enough what KDUS technology went to Axiom. Mainly, I was wondering what the overall added value/necessity is of the yeast screen to someone doing GPCR screens. Like you said, I wasn't thinking in terms of Telik. Arena just seemed like a more than fair price in the same area. I need to read about Arena too; it would be interesting to see how competitive they are in their all-the-GPCRs-in-the-genome mapping project. They recently announced the status. i think several pharmas have been on this same strategy for a long time - i wonder where they are. Noticed two exNBIX scientist are VPs R&D. Do you know much about them? I should go hit medline. Luke

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next